Martínez-González, L.; Gonzalo-Consuegra, C.; Gómez-Almería, M.; Porras, G.; de Lago, E.; Martín-Requero, Á.; Martínez, A.
Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2021, 22, 8975.
https://doi.org/10.3390/ijms22168975
AMA Style
Martínez-González L, Gonzalo-Consuegra C, Gómez-Almería M, Porras G, de Lago E, Martín-Requero Á, Martínez A.
Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. 2021; 22(16):8975.
https://doi.org/10.3390/ijms22168975
Chicago/Turabian Style
Martínez-González, Loreto, Claudia Gonzalo-Consuegra, Marta Gómez-Almería, Gracia Porras, Eva de Lago, Ángeles Martín-Requero, and Ana Martínez.
2021. "Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis" International Journal of Molecular Sciences 22, no. 16: 8975.
https://doi.org/10.3390/ijms22168975
APA Style
Martínez-González, L., Gonzalo-Consuegra, C., Gómez-Almería, M., Porras, G., de Lago, E., Martín-Requero, Á., & Martínez, A.
(2021). Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences, 22(16), 8975.
https://doi.org/10.3390/ijms22168975
